Catalyst Wire Dossier Catalyst Wire Dossier

Symlin (pramlintide)

pramlintide · AstraZeneca
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Symlin (pramlintide), covering 2015-06-11 to 2015-06-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Examine the Long Term Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects [Phase 2]

See pricing